Valentina Z.
- Country
- Italy
- Department
- ostetricia e ginecologia
Research Overview
- A Phase II randomized, open label non-inferiority study of NiraParib maintenance after 3 vs. 6 cycles of platinum-based chemotherapy in completeLy debUlked advanced HRDpositive high-grade ovarian cancer patientS in first line therapy
- Phase II Study of Cemiplimab Before and After Standard Chemoradiotherapy in Patients With Locally Advanced Cervical Carcinoma
Data & Insights
Has run more than one trial at 3 of 51 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating advanced forms of gynecological cancers, with particular emphasis on ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
- High-grade ovarian cancer treatment
- Clear cell carcinoma management
- Post-surgical therapy optimization
Focus areas include evaluation of tumor debulking outcomes and treatment strategies for HRD-positive cases.
Treatment Innovation
The investigator explores innovative therapeutic approaches in advanced stage gynecologic cancers, particularly focusing on maintenance therapy strategies and optimized treatment durations.
- Maintenance therapy protocols
- Chemotherapy optimization
- Recurrence prevention strategies
Expertise includes assessment of recurrence-free survival in various treatment protocols.
Precision Medicine
The investigator's work encompasses targeted therapeutic approaches for specific patient populations, particularly those with HRD-positive tumors.
- HRD-positive cancer treatment
- Stage-specific protocols
- FIGO classification-based therapy
Special attention is given to developing treatment protocols for advanced-stage cases classified under FIGO stages IIIA through IV.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.